Global life sciences company Repligen is expanding its manufacturing operations in Waterford, with plans to fit out a 33,000 square foot building that is expected to create 130 jobs over the next two and a half years.
The new Repligen facility will serve as a Centre of Excellence for single-use consumable products used in bioprocessing applications.
It will complement the existing 10,500 square foot Waterford facility, which was formerly ARTeSYN BioSolutions and which Repligen acquired in December 2020. It currently employs 74 people.
The expansion comes as Repligen continues to experience rapid growth and increased demand for its bioprocessing products.
Repligen's expansion in Waterford is supported by IDA Ireland.
James Bylund, Senior Vice-President, Global Operations and Information Technology at Repligen, said the buildout is an important step in expanding its capacity and establishing dual manufacturing sites for key single-use consumable products used in manufacture of biological drugs.
IDA Ireland CEO Martin Shanahan said the company's next phase of growth is further evidence that the technological expertise in the region is strong and that the South East is an attractive location in which to invest, work and live.
" IDA Ireland is fully committed to regional development and ensuring every area benefits from employment gains. We are pleased to partner with innovation-driven companies like Repligen to increase economic growth and employment in the South East region," Mr Shanahan added.
Tánaiste and Minister for Enterprise, Trade & Employment Leo Varadkar today's jobs news comes on foot of a major jobs announcement by Bausch and Lomb.
"Waterford is on the move as a centre for jobs and investment. Ireland is globally recognised as a centre of excellence for life sciences and this significant expansion is a real vote of confidence in us and our capacity," Mr Varadkar said.
"It shows we are succeeding in attracting high-calibre companies and highly-skilled jobs to all our regions," he added.